Parametric Portfolio Associates’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $685K | Buy |
43,161
+7,340
| +20% | +$116K | ﹤0.01% | 2949 |
|
|
2021
Q4 | $782K | Sell |
35,821
-13,913
| -28% | -$304K | ﹤0.01% | 2885 |
|
|
2021
Q3 | $1.49M | Sell |
49,734
-11,463
| -19% | -$343K | ﹤0.01% | 2605 |
|
|
2021
Q2 | $2.71M | Sell |
61,197
-39,885
| -39% | -$1.77M | ﹤0.01% | 2261 |
|
|
2021
Q1 | $4.49M | Buy |
101,082
+55,007
| +119% | +$2.44M | ﹤0.01% | 2259 |
|
|
2020
Q4 | $2.53M | Buy |
46,075
+32,328
| +235% | +$1.77M | ﹤0.01% | 2513 |
|
|
2020
Q3 | $314K | Sell |
13,747
-96
| -0.7% | -$2.19K | ﹤0.01% | 3466 |
|
|
2020
Q2 | $290K | Buy |
13,843
+3,119
| +29% | +$65.3K | ﹤0.01% | 3485 |
|
|
2020
Q1 | $150K | Sell |
10,724
-13,338
| -55% | -$187K | ﹤0.01% | 3629 |
|
|
2019
Q4 | $548K | Buy |
24,062
+998
| +4% | +$22.7K | ﹤0.01% | 3341 |
|
|
2019
Q3 | $269K | Buy |
23,064
+10,659
| +86% | +$124K | ﹤0.01% | 3595 |
|
|
2019
Q2 | $186K | Buy |
+12,405
| New | +$186K | ﹤0.01% | 3756 |
|
|
2017
Q3 | – | Sell |
-7,045
| Closed | -$54K | – | 4046 |
|
|
2017
Q2 | $54K | Sell |
7,045
-107
| -1% | -$820 | ﹤0.01% | 3959 |
|
|
2017
Q1 | $57K | Buy |
+7,152
| New | +$57K | ﹤0.01% | 3728 |
|